Literature DB >> 102659

Genetic control of retinal ganglion cell projections.

J H LaVail, R A Nixon, R L Sidman.   

Abstract

We have assessed the effects of 15 pigmentation mutations on the development of retinal ganglion cell projections in mice in two ways: (1) by analyzing the pattern of innervation of the ipsilateral lateral geniculate nucleus as mapped in autoradiograms of brains of animals killed 12 days after intravitreal injection of 3H-proline into one eye and (2) by determining the ratio of axonally transported radioactive protein in the contralateral and ipsilateral optic tracts after similar intravitreal injections. Analysis of the ratio of transported protein in the two optic tracts provides a new and useful assay of the degree of decussation in experimental animals. The effects of the mutations on eye pigmentation, whole eye melanin content and relative tyrosinase activity also were examined. The degree of ipsilateral innervation generally correlates with the degree of pigmentation of the retinal pigment epithelium and with tyrosinase activity. However, discrepancies have been found in ch and ce mutants. In these animals the pigment epithelium is well pigmented, and the area of ipsilateral innervation in the lateral geniculate nucleus is extensive, despite a high ratio of label in contralateral to ipsilateral optic tracts and low tyrosinase activity. Furthermore, mice heterozygous for the c2J allele have pigmentation and optic projections that are normal even though tyrosinase is reduced to 40% of normal. The few anomalous results suggest that alternative or additional factors may control optic axon projections.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102659     DOI: 10.1002/cne.901820304

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  33 in total

1.  The clinical features of albinism and their correlation with visual evoked potentials.

Authors:  S E Dorey; M M Neveu; L C Burton; J J Sloper; G E Holder
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

Review 2.  Development of the retina and optic pathway.

Authors:  Benjamin E Reese
Journal:  Vision Res       Date:  2010-07-18       Impact factor: 1.886

3.  The Tyr (albino) locus of the laboratory mouse.

Authors:  Friedrich Beermann; Seth J Orlow; M Lynn Lamoreux
Journal:  Mamm Genome       Date:  2004-10       Impact factor: 2.957

Review 4.  Conversations with Ray Guillery on albinism: linking Siamese cat visual pathway connectivity to mouse retinal development.

Authors:  Carol Mason; Ray Guillery
Journal:  Eur J Neurosci       Date:  2019-04-23       Impact factor: 3.386

5.  The pearl mutation accelerates the schedule of natural cell death in the early postnatal retina.

Authors:  M A Williams; L G Piñon; R Linden; L H Pinto
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

Review 6.  Albinism: modern molecular diagnosis.

Authors:  S M Carden; R E Boissy; P J Schoettker; W V Good
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

7.  Tyrosinase expression during neuroblast divisions affects later pathfinding by retinal ganglion cells.

Authors:  Carolyn A Cronin; Amy B Ryan; Edmund M Talley; Heidi Scrable
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

8.  Evidence for the delayed expression of a brainstem abnormality in albino ferrets.

Authors:  G E Baker; R W Guillery
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

9.  Developmental genetics of the retina: evidence that the pearl mutation in the mouse affects the time course of natural cell death in the ganglion cell layer.

Authors:  R Linden; L H Pinto
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

10.  Reduced influence of the ipsilateral ear on spatial tuning of auditory neurons in the albino superior colliculus: a knock-on effect of anomalies of the acoustic chiasm?

Authors:  Simon Grant; K Esther Binns
Journal:  Exp Brain Res       Date:  2003-06-27       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.